In CRC, Zhong et al. (23) indicated that COMP is aberrantly highly expressed in CRC tissues, and that it interacts with TAGLN in vivo and in vitro, leading to cytoskeleton remodeling to promote the EMT process. The gene discussed is TAGLN; the disease is colorectal carcinoma.